USPTO 2015–2025 USPTO PatentsView US Corporation

Fluence Bioengineering, Inc.

USPTO PatentsView assignee record - 68 granted patents across 30 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01G (HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING).

68
Total patents granted
30
CPC technology areas
13.8
Avg claims per patent
+200%
5-year filing velocity

The verdict

Fluence holds 68 US patents across 30 technology areas, rank #5,072 of 50,000 tracked assignees.

#5,072
of 50,000 US assignees by volume
Top 26%
by Innovation Score (44.3/100)
13.8
avg claims per patent
+200%
filing velocity, last 5 yrs

Portfolio overview

Fluence Bioengineering, Inc. has been granted 68 US utility patents between 2017 and 2025, placing Fluence Bioengineering, Inc. at rank #5,072 across all assignees tracked by PlainPatent. This portfolio spans 30 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.8 claims per patent with primary concentration in A01G (HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING). As a US Corporation, Fluence Bioengineering, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Fluence sits between Daimler Truck Ag (68 patents, rank #5,068) and Hill's Pet Nutrition, Inc. (68 patents, rank #5,076) - the closest US assignees by grant volume. The composite Innovation Score of 44.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 51 grants, compared with 17 in the 2015–2019 window, a +200% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Fluence Bioengineering, Inc.'s 13.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 30 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fluence Bioengineering, Inc. against peers pursuing similar technology classes.

Who files at Fluence's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Fluence holds 68 patents at rank #5,072, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Fluence

By rank, the assignees closest to #5,072 in granted patent volume.

Leaders in A01G (Horticulture)

Other assignees with the most granted patents in Fluence's primary technology class.

Fluence's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20172018201920202021202220232025 2
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Fluence Bioengineering, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 1.5%
2018 2 2.9%
2019 14 20.6%
2020 15 22.1%
2021 19 27.9%
2022 8 11.8%
2023 7 10.3%
2025 2 2.9%

Which technologies does Fluence Bioengineering, Inc. patent most?

Top 15 of 30 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#5,072

Across all tracked assignees

Innovation Score

44.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Fluence Bioengineering, Inc. hold?
Fluence Bioengineering, Inc. holds 68 US granted patents filed between 2017 and 2025, spanning 30 technology areas.
What is Fluence Bioengineering, Inc.'s Innovation Score?
Fluence Bioengineering, Inc. has an Innovation Score of 44.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Fluence Bioengineering, Inc. focus on?
Fluence Bioengineering, Inc.'s top technology area is A01G (HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING) with 48 patents. The company has filed patents in 30 CPC subclasses total.
Is Fluence Bioengineering, Inc.'s patent filing rate increasing or decreasing?
Fluence Bioengineering, Inc.'s recent filing velocity is +200% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Fluence Bioengineering, Inc.'s patents?
Fluence Bioengineering, Inc.'s patents average 13.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the Fluence Bioengineering, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Fluence's 68 grants land it in the top 26% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Fluence ranks #5,072 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A01G - see who else leads that technology area. A01G leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.